연사

Feasibility & Site Selection


Lale Akca, MBA, CCRA, Executive Director, Clinical Trials Unit, University of Louisville
Peter Bergethon, MD, Vice President, Head of Digital and Quantitative Medicine, Biogen
Christina Brennan, MD, MBA, Vice President, Clinical Research, Northwell Healthcare
MarieElena Cordisco, MA, APRN, NP-C, Nuvance Health; Director Clinical Trials, Western Connecticut Health Network; Interim Director, Division of Research, Health Quest
Annick de Bruin, MBA, Director, Research Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Ronald Dorenbos, PhD, Head, Innovation Management & Scouting, Innovation & Technology Science, Takeda
Alik Farber, MD, Chief, Division of Vascular and Endovascular Surgery, Associate Chair for Clinical Operations, Department of Surgery, Boston Medical Center; Professor of Surgery and Radiology, Boston University School of Medicine
Gabriela Feldberg, Practice Leader, Applied Analytics & Artificial Intelligence, AstraZeneca
Kaitlin Folweiler, PhD, Data Scientist, R&D Data Science, Analytics and Insights, Janssen
Jane Hart, Vice President, Global Clinical Affairs, Acelity
Amanda Hayden, Senior Director, Global Clinical Services, Clinical Operations, Alkermes
Justin Hensperger, MS, Clinical Trial Science, Site Intelligence Lead – Associate Director, Internal Medicine, Pfizer
Phyllis Kaplan, Trial Volunteer and Patient with T1D
Marcy Kravet, BS, MBA, Head, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Hugh Levaux, Founder and CEO, Protocol First
Rob Long, Executive Director, Uplifting Athletes
Alan Louie, PhD, Research Director, Life Sciences, IDC Health Insights
Brandon Maggio, Associate Director, Global Clinical Operations, Boehringer Ingelheim Pharmaceuticals
Beth Mahon, Global Feasibility Therapeutic Area (TA) Head, Feasibility Center of Excellence (FCoE), Clinical Insights and Experience, Oncology, Janssen
Charles Makin, Global Head, Real World Evidence Strategy, Biogen
Sylvia Marecki, PhD, Design Analyst, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Jane Myles, Founder and Director, JemTech; Former Head, Operational Intelligence and Innovation, Roche
Len Rosenberg, PhD, RPh, Head, Clinical Operations, Beat AML/LLS
Rangaprasad Sarangarajan, PhD, CSO & Senior Vice President, Clinical and Translational Sciences, Research & Development, BERG
Sarb Shergill, Global Head of Project Leaders, Genzyme
Sandra Smyth, Head, Global Feasibility & Site Intelligence, AstraZeneca
Maura Snyder, MBA, Global Head, Clinical Trial Engagement, Clinical Insights and Experience, Janssen Pharmaceuticals

Data & Technology

Liz Beatty, Chief Strategy Officer, Inato
Peter Bergethon, MD, Vice President, Head of Digital and Quantitative Medicine, Biogen
Don Berry, PhD, Founder & Senior Statistical Scientist, Berry Consultants, LLC; Professor, Biostatistics, University of Texas MD Anderson Cancer Center
Susan Bornstein, MPH, Senior Director, Data Monitoring and Data Management, Global Product Development, Pfizer Inc.
Annick de Bruin, MBA, Director, Research Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Matt De Silva, Founder and CEO, Notable
Ronald Dorenbos, PhD, Head, Innovation Management & Scouting, Innovation & Technology Science, Takeda
Alik Farber, MD, Chief, Division of Vascular and Endovascular Surgery, Associate Chair for Clinical Operations, Department of Surgery, Boston Medical Center; Professor of Surgery and Radiology, Boston University School of Medicine
Eric Gildenhuys, Vice President, Business Development, Deep 6 AI
Phyllis Kaplan, Trial Volunteer and Patient with T1D
Deborah Kilpatrick, PhD, Evidation Health
Judith Kornfeld, Chief Business and Operations Officer, ORCATECH, Oregon Health and Sciences University
Marcy Kravet, BS, MBA, Head, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Jake LaPorte, Co-Founder & Global Head of the Novartis Biome, Novartis
Rob Long, Executive Director, Uplifting Athletes
Alan Louie, PhD, Research Director, Life Sciences, IDC Health Insights
Charles Makin, Global Head, Real World Evidence Strategy, Biogen
Sylvia Marecki, PhD, Design Analyst, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Ijah Mondesire-Crump, MD, Research Director, nQ Medical Inc
Sam Roosz, Co-Founder, Head of Life Sciences, Datavant
Rangaprasad Sarangarajan, PhD, CSO & Senior Vice President, Clinical and Translational Sciences, Research & Development, BERG
Maura Snyder, MBA, Global Head, Clinical Trial Engagement, Clinical Insights and Experience, Janssen Pharmaceuticals
Robert Wilson III, Consultant, Wilson Digital Health Consulting


Engagement & Enrollment

Karen Anderson, Senior Director, Medical Affairs, Rare Genetic Disease, Agios Pharma
Peter Bergethon, MD, Vice President, Head of Digital and Quantitative Medicine, Biogen
Jennifer Brandl, Senior Clinical Trial Manager, Kezar Life Sciences
Bonnie Brescia, Founding Principal, BBK Worldwide
Richard Brescia, Cancer Survivor and Three-Time Clinical Trial Participant
Joan Chambers, Senior Director, Marketing & Outreach, CISCRP
Tim Coetzee, Chief Advocacy, Services and Research Officer, The National MS Society
Cathy Critchlow, PhD, Vice President, Center for Observational Research, Amgen
Emma D’Agostino, CF Patient, Member of FDA Review Committee
Annick de Bruin, MBA, Director, Research Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Nan Doyle, R&D Patient Engagement Lead, Rare Disease, Takeda
Alik Farber, MD, Chief, Division of Vascular and Endovascular Surgery, Associate Chair for Clinical Operations, Department of Surgery, Boston Medical Center; Professor of Surgery and Radiology, Boston University School of Medicine
Rodrigo Garcia, MD, Head, Clinical Innovation, EMD Serono
Rose Gerber, Director, Patient Advocacy and Education, Community Oncology Alliance (COA); 3x Clinical Trial Participant
Katie Goodman, RN, Director, Clinical Research, Florida Cancer Specialists & Research Institute
Keyla Deucher, Head, Clinical Trial Unit, Hospital Sao Vicente
Kevonna Hayes, Senior Program Coordinator, Greater Gift
Ben Illigens, MD, PhD, CEO, UniMedIT Germany; Professor, Harvard Medical School
Phyllis Kaplan, Trial Volunteer and Patient with T1D
Helen Kellar-Wood, PhD, Associate Director, Oncology and Immunoscience Lead, Diversity & Patient Engagement, Bristol-Myers Squibb
Michael Keens, COO, Firma Clinical
Marcy Kravet, BS, MBA, Head, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Mary Jo Lamberti, PhD, Associate Director and Research Assistant Professor, Tufts Center for the Study of Drug Development (CSDD)
Rob Long, Executive Director, Uplifting Athletes
Alan Louie, PhD, Research Director, Life Sciences, IDC Health Insights
Charles Makin, Global Head, Real World Evidence Strategy, Biogen
Sylvia Marecki, PhD, Design Analyst, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Mary McGowan, Executive Director, The Myositis Association
Gayle McCracken, Vice President, Market Innovation, Spencer Health Solutions, Inc.
Mary Murray, Associate Director, Oncology Lead, Diversity & Patient Engagement, Bristol-Myers Squibb
Jane Perlmutter, PhD, MBA, Independent Patient Advocate, Advisor, Patient- Centered Outcomes Research Institute (PCORI)
Ian Rentsch, CEO, Clinerion Ltd.
Christina Roman, MPH, Senior Manager, Community Engagement, Community Partnerships, Cystic Fibrosis Foundation
Len Rosenberg, PhD, RPh, Head, Clinical Operations, Beat AML, a division within the Leukemia and Lymphoma Society
Rangaprasad Sarangarajan, PhD, CSO & Senior Vice President, Clinical and Translational Sciences, Research & Development, BERG
Maura Snyder, MBA, Global Head, Clinical Trial Engagement, Clinical Insights and Experience, Janssen Pharmaceuticals
Leah Szumita, MSN, Associate Director, Nursing, Clinical Trial Support Center, Beat AML, a division within the Leukemia and Lymphoma Society
Patricia Weltin, CEO/Founder, Beyond the Diagnosis
Speaker to be Announced, Maya Angelou Center for Health Equity (MACHE)
Speaker to be Announced, AstraZeneca
Speaker to be Announced, Roche

Risk-Based Monitoring

Lucien Agnant, Associate Program Manager, Otsuka Pharmaceutical Development & Commercialization, Inc.
Muhammad Ali, Central Monitoring, Pfizer
Peter Bergethon, MD, Vice President, Head of Digital and Quantitative Medicine, Biogen
Annick de Bruin, MBA, Director, Research Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Kevin Douglass, Associate Director, Process Excellence & Risk Management, Daiichi Sankyo, Inc.
Anna Gibernau, PhD, MSc, PMP, EDP, Clinical Research Consultant & Professor Pharmaceutical Law, Clinical Operations, Clementine Global S.L./Barcelona University
Alik Farber, MD, Chief, Division of Vascular and Endovascular Surgery, Associate Chair for Clinical Operations, Department of Surgery, Boston Medical Center; Professor of Surgery and Radiology, Boston University School of Medicine
Laura Galuchie, TransCelerate Program Lead, Oversight Committee, TransCelerate Biopharma Inc.
Laurie Halloran, CEO, Halloran Consulting Group, Inc.
Phyllis Kaplan, Trial Volunteer and Patient with T1D
Amy Klawitter, Senior Manager, Clinical Management, Otsuka Pharmaceutical Development & Commercialization, Inc.
Sheri Kuss, Clinical Quality Lead, Clinical Development Quality, Global Product Development, Pfizer, Inc.
Marcy Kravet, BS, MBA, Head, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Andy Lawton, Director & Consultant, Risk Based Approach Ltd.
Rob Long, Executive Director, Uplifting Athletes
Alan Louie, PhD, Research Director, Life Sciences, IDC Health Insights
Charles Makin, Global Head, Real World Evidence Strategy, Biogen
Sylvia Marecki, PhD, Design Analyst, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Amy Neubauer, Director, Data Quality Oversight, Alkermes
Catalina Ortiz, Principal Business Operations Analyst, Vertex Pharmaceuticals
Jonathan Rowe, PhD, Executive Director & Head, Quality Performance and Risk Management, Pfizer
Rangaprasad Sarangarajan, PhD, CSO & Senior Vice President, Clinical and Translational Sciences, Research & Development, BERG
Maura Snyder, MBA, Global Head, Clinical Trial Engagement, Clinical Insights and Experience, Janssen Pharmaceuticals
Linda Sullivan, Co-Founder & Executive Director, WCG - Metrics Champion Consortium
Diane Thornton Chandler, BSN, RBM/Centralized Monitoring Lead

Budgeting & Outsourcing

Debora Araujo, Founder & CEO, ClinBiz
Peter Bergethon, MD
, Vice President, Head of Digital and Quantitative Medicine, Biogen
Deena Bernstein, Consultant, Kelly Willenberg, LLC
Chuck Bradley, Vice President, Clinical Development, FibroGen, Inc.
Annick de Bruin, MBA, Director, Research Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Alik Farber, MD, Chief, Division of Vascular and Endovascular Surgery, Associate Chair for Clinical Operations, Department of Surgery, Boston Medical Center; Professor of Surgery and Radiology, Boston University School of Medicine
Phyllis Kaplan, Trial Volunteer and Patient with T1D
Ly Kawaguchi, Senior Director, Head, Outsourcing and Procurement, MyoKardia
Marcy Kravet, BS, MBA, Head, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Andy Lawton, Director & Consultant, Risk Based Approach Ltd.
Rob Long, Executive Director, Uplifting Athletes
Alan Louie, PhD, Research Director, Life Sciences, IDC Health Insights
Charles Makin, Global Head, Real World Evidence Strategy, Biogen
Marina Malikova, PhD, Executive Director, Surgical Translational Research: Operations and Compliance, Boston University School of Medicine
Sylvia Marecki, PhD, Design Analyst, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
Cameron McClure, PMP, PMI-ACP, CSM, CCRP, Senior Manager, Clinical Business Operations, BeiGene
Erin O’Boyle, Senior Director, Clinical Operations, Rezolute, Inc.
Dennis Salotti, COO, The Avoca Group
Rangaprasad Sarangarajan, PhD, CSO & Senior Vice President, Clinical and Translational Sciences, Research & Development, BERG
Scott Sawicki, R&D Sourcing Consultant, Adare Pharmaceuticals
Bella Sessoms, MPH, Director, Portfolio Sourcing Management, Portfolio Sourcing and Relationship Management, Astellas Pharma Global Development
Maura Snyder, MBA, Global Head, Clinical Trial Engagement, Clinical Insights and Experience, Janssen Pharmaceuticals
Kelly Willenberg, DBA, BSN, CHRC, CHC, CCRP, Consultant, Kelly Willenberg, LLC
Jay Zinni, Director, R&D Procurement, Incyte

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English



Catalog Download
Catalog


From the Producers of:

From the Producers of SCOPE

메일링 서비스